CLINICAL ROLE -
Measuring Outcomes in Atopic Dermatitis
Atopic Dermatitis: Cost and Value
Understanding Emerging Therapies in Atopic Dermatitis
Weighing Quality of Life Improvements in Atopic Dermatitis
Atopic Dermatitis: Current and Future Management
Persistent and Recurrent Atopic Dermatitis
How Can Access to PCSK9 Inhibitors be Improved?
Mark Tesell, PharmD, BCPS, clinical consultant pharmacist for UMass Medical School Clinical Pharmacy Services, discusses potential solutions for access to cholesterol lowering drugs to improve.
Scrutiny of High Drug Costs Require Specialty Pharmacy Strategy Shift
Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses how specialty pharmacies may need to alter current strategies with increasing attention on high drug costs.
Overcoming High Copays to Improve Drug Adherence
Rebekah L. Hanson, PharmD, BCPS, BCACP, clinical pharmacist and assistant professor at the UIC College of Pharmacy, discusses the challenge of out-of-pocket spending and the impact on drug adherence.
How Can Access to Costly Specialty Drugs be Improved?
Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses challenges for patients in accessing specialty medications.
Balancing Cost and Care in Specialty Pharmacy
Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses challenges balancing the quality of care with the high cost of treatments.
How Incorporating Patient Perspectives Can Improve Health Care
Eric Peacock, co-founder and CEO of MyHealthTeams, how bringing the voice of patients to clinical research can enhance health care.
Pharmacy Job Placement Efforts of the American Association of Colleges of Pharmacy
Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), discusses the pharmacy job placement efforts of the AACP.
How Will Spending Growth Impact the Specialty Pharmacy Patient Experience?
Daniel P. Kus, BS Pharm, RPh, discusses how the growth of drug prices could impact the specialty pharmacy patient experience.
How Pharmacy Associations Work in Collaboration
Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), explains how pharmacy associations work in collaboration.
The Impact of Limited Distribution Networks on Specialty Pharmacy
Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses how specialty pharmacies can navigate limited distribution networks.
How Pharmacy School Curriculums Have Changed
Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), describes how pharmacy school curriculums have changed.
Collaborations with the American Association of Colleges of Pharmacy
Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), discusses collaborations with the AACP.
How Can Pharmacies Become Sites for Student Rotations?
Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), explains how pharmacies can become sites for student rotations.
Effective Techniques to Boost Specialty Drug Adherence
Rebekah L. Hanson, PharmD, BCPS, BCACP, clinical pharmacist and assistant professor at the UIC College of Pharmacy, discusses medication management processes that can improve adherence to specialty therapies.
How Can Practicing Pharmacists Become Preceptors?
Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), explains how practicing pharmacists can become preceptors.
Improving Alignment Among Specialty Pharmacy Stakeholders
Marc O'Connor, COO and chief strategy officer at Curant Health, discusses actions that can enhance the relationship between manufacturers, payers, providers and patients in specialty pharmacy.
How Students Can Engage With the American Association of Colleges of Pharmacy
Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), discusses how students can engage with the AACP.
Were PCSK9 Inhibitors Overhyped?
Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses access to cholesterol-lowering PCSK9 inhibitors and whether the hype regarding the impact of these medications was overblown.
Hidden Costs for Patients Starting a Specialty Drug Regimen
Marc O'Connor, COO and chief strategy officer at Curant Health, discusses the out-of-pocket costs that can emerge for patients starting a specialty medication regimen.
When Should Patients Switch from Statins to PCSK9 Inhibitors?
Mark Tesell, PharmD, BCPS, clinical consultant pharmacist at UMass Medical School, discusses the treatment switch from statins to PCSK9 inhibitors in patients with high cholesterol.
How High Cost Oncology Drugs Are Changing Specialty Pharmacy
Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses the impact of oncology medications and how specialty pharmacies can adjust.
How Will Growing Government Scrutiny Impact Specialty Pharmacy?
Mark A. Vineis, vice president of Specialty Pharmacy of Cardinal Health, discusses how the increased interest of the federal government in escalating drug prices may impact specialty pharmacy.
Using Patient Feedback Surveys in Specialty Pharmacy
Paul LeVine, vice president of Analytic Services at TrialCard, discusses how specialty pharmacies can use patient feedback surveys to improve treatment outcomes.
Optimal Patient Management in Hepatitis C Treatment
Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses the components of an effective patient management program to optimize adherence.
